Exenatide

FDA-approved product existsMetabolic ResearchWeight & metabolic

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Exenatide?

FDA-approved exenatide products exist for improving glycemic control in specified patients with type 2 diabetes. Immediate-release and extended-release formulations have different schedules and handling.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelExenatide injection prescribing information for type 2 diabetes
PopulationAdults covered by the approved indication
DoseStart at 5 mcg twice daily; after one month the label permits an increase to 10 mcg twice daily based on clinical response.
RouteSubcutaneous injection in the thigh, abdomen, or upper arm
FrequencyTwice daily within 60 minutes before the morning and evening meals, at least 6 hours apart
DurationLong-term use within the approved indication
PreparationReady-to-use 250 mcg/mL solution in 5 mcg and 10 mcg-per-dose prefilled pens; no reconstitution.
Source: Dosage and Administration section 2.1; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved products exist; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.